DIN 02358743 — NOREPINEPHRINE BITARTRATE INJECTION, USP 1 MG
NOREPINEPHRINE BITARTRATE INJECTION, USP is a solution of Norepinephrine marketed by STERIMAX INC. The full Norepinephrine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02358743
- Brand name
- NOREPINEPHRINE BITARTRATE INJECTION, USP
- Active ingredient
- Norepinephrine
- Strength
- 1 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- STERIMAX INC
- Health Canada status
- MARKETED
- Drug class
- Sympathomimetic vasopressor (alpha- and beta-adrenergic agonist)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Norepinephrine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02501430 | NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION | 0.016 MG | SOLUTION | BAXTER CORPORATION | MARKETED |
| 02501449 | NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION | 0.032 MG | SOLUTION | BAXTER CORPORATION | MARKETED |
| 02540630 | NOREPINEPHRINE BITARTRATE INJECTION | 1 MG | SOLUTION | JUNO PHARMACEUTICALS CORP. | MARKETED |
| 00893285 | NOREPINEPHRINE BITARTRATE INJECTION USP | 1 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02485680 | NOREPINEPHRINE BITARTRATE INJECTION USP | 1 MG | SOLUTION | GENERIC MEDICAL PARTNERS INC | DORMANT |